NCT02471950

Brief Summary

There is no clinical way of assessing the depth of anaesthesia while patients are on the heart-lung machine. A new method of measuring the depth of anaesthesia using brainwaves called the Bispectral index (BIS) has been developed and its use in cardiac surgery is now widespread. However BIS is also altered by patients body temperature. As cooling is common during heart surgery the use of BIS to measure the depth of anaesthesia during heart-lung bypass remains controversial. This study aims to find out what depth of anaesthesia is produced according to BIS during heart lung bypass using a standard anaesthetic technique that utilises the anaesthetic isoflurane.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 15, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

3.8 years

First QC Date

June 1, 2015

Last Update Submit

June 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Depth of anesthesia according to BIS

    BIS reading will be recorded at three time points during cardiopulmonary bypass

    Intraoperative

Secondary Outcomes (3)

  • Comparison of exhaust gas and blood concentration of isoflurane

    Intraoperative

  • Comparison of blood isoflurane concentration and BIS score

    Intraoperative

  • Comparison of exhaust isoflurane Concentration and BIS score

    Intraoperative

Study Arms (1)

Elective Cardiac surgery

Those patients scheduled for elective heart surgery requiring cardiopulmonary bypass who will be given 2.5% isoflurane while on bypass.

Procedure: 2.5 % Isoflurane administration

Interventions

Anaesthesia maintained during cardiopulmonary bypass with 2.5% isoflurane administered via the oxygenator of the bypass circuit.

Elective Cardiac surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Those patients scheduled for elective heart surgery over the age of 18 requiring cardiopulmonary bypass

You may qualify if:

  • Participants over the age of 18
  • Scheduled for elective cardiac surgery under the care of trial anaesthetists
  • Patient has provided informed consent to participate

You may not qualify if:

  • Patients presenting for emergency cardiac surgery
  • Patients who will have cardiac surgery that does not require cardiopulmonary bypass
  • Unwilling/unable to provide informed consent
  • Patients under the age of 18
  • Anaesthesia undertaken by anaesthetists not involved in trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Infirmary of Edinburgh

Edinburgh, Scotland, EH16 4SA, United Kingdom

Location

Related Publications (1)

  • Alston RP, Connelly M, MacKenzie C, Just G, Homer N. The depth of anaesthesia associated with the administration of isoflurane 2.5% during cardiopulmonary bypass. Perfusion. 2019 Jul;34(5):392-398. doi: 10.1177/0267659118822946. Epub 2019 Jan 12.

Biospecimen

Retention: SAMPLES WITH DNA

Arterial and venous blood samples

Study Officials

  • Peter Alston, MBChB

    University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2015

First Posted

June 15, 2015

Study Start

April 1, 2015

Primary Completion

January 1, 2019

Study Completion

January 1, 2019

Last Updated

June 21, 2021

Record last verified: 2021-06

Locations